Sana Biotechnology, Inc. (SANA)
1.88
-0.14
(-6.93%)
USD |
NASDAQ |
Nov 16, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Total Assets (Quarterly) : 376.13M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 376.13M |
| June 30, 2026 | 431.52M |
| March 31, 2026 | 373.59M |
| December 31, 2025 | 426.72M |
| September 30, 2025 | 435.43M |
| June 30, 2025 | 361.64M |
| March 31, 2025 | 445.47M |
| December 31, 2024 | 501.02M |
| September 30, 2024 | 559.39M |
| June 30, 2024 | 618.67M |
| March 31, 2024 | 681.38M |
| December 31, 2023 | 565.30M |
| September 30, 2023 | 631.44M |
| June 30, 2023 | 707.15M |
| Date | Value |
|---|---|
| March 31, 2023 | 746.93M |
| December 31, 2022 | 822.72M |
| September 30, 2022 | 898.10M |
| June 30, 2022 | 971.09M |
| March 31, 2022 | 1.048B |
| December 31, 2021 | 1.129B |
| September 30, 2021 | 1.233B |
| June 30, 2021 | 1.260B |
| March 31, 2021 | 1.304B |
| December 31, 2020 | 730.30M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 415.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 902.56M |
| Twist Bioscience Corp. | 1.122B |
| Beam Therapeutics, Inc. | 1.269B |
| Revolution Medicines, Inc. | 4.304B |
| Prelude Therapeutics, Inc. | 189.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 195.76M |
| Shareholders Equity (Quarterly) | 180.36M |
| Debt to Equity Ratio | 0.2985 |
| Current Ratio | 1.767 |
| Net Debt Paydown Yield | 0.72% |